Reactive inflammatory processes in response to emerging pathologies in the brain are suggested to interact with, and accelerate, the neurodegenerative processes, which may further explain observations that high baseline CRP levels in cognitively healthy individuals increase the risk of developing dementia in later years (Lewis and Knight, 2021; Schmidt et al., 2002). The gene discussed is CRP; the disease is dementia.